Cited by 23Protein Degradation and InhibitorsCytokine Signaling Pathways and InteractionsHistone Deacetylase Inhibitors Research

Inhibit versus Destroy: Are PROTAC Degraders the Solution to Targeting STAT3?

Open access
Heppler, Lisa N., Frank, David A.·2019·Cancer Cell

Abstract

Despite the role of STAT3 as a known driver of oncogenesis, efforts to develop therapeutic STAT3 inhibitors have thus far been unsuccessful. In this issue of Cancer Cell, Bai et al. report a potent and selective STAT3 degrader capable of producing complete and long-lasting tumor regression in mouse xenograft models.

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2019.10.010

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

The citation lists haven’t been fetched yet

References 10 · Cited by 23

Authors
Heppler, L. N., & Frank, D. A.
Affiliations
  • Dana-Farber Cancer Institute (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Frank, David A.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2019-11
Volume
36
Issue
5
Pages
459-461
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2988338102
Cited by
23
References
10
Citations by year
2025: 2 · 2024: 6 · 2023: 3 · 2022: 7 · 2021: 1 · 2020: 3 · 2019: 1
FWCI
0.99
Type
journal article
Language
en
Open access
Locations
  • Cancer Cell (publishedVersion)
  • PubMed (publishedVersion)
Funders
Gilead Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
Keywords
PROTAC degraders, STAT3, protein degradation, STAT3 inhibitor, carcinogenesis, tumor regression, xenograft mouse model, targeted cancer therapy
MeSH terms
Animals, Humans, Neoplasms, Cell Line, Tumor, STAT3 Transcription Factor, Mice, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review